For generations, the architecture of medical research has imposed a kind of enforced patience — years spent navigating institutions before a single clinical question could be answered. In Israel, a dermatology resident studying a rare blistering disorder completed in six weeks what would once have taken two years, by pairing crowdsourced patient-reported data with AI-assisted analysis. The achievement is not merely one of speed; it is a quiet rearrangement of who gets to ask questions, and how quickly the answers can reach the people who need them.